Life Sciences Analytics Market is Poised to reach USD 68.32 Billion by 2030, Driven by R&D Efficiency and Demand from Biomedical Data Surge

Mordor Intelligence has published a new report on the Life Sciences Analytics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global life sciences analytics market is hitting a notable benchmark, projected to reach US $39.83 billion in 2025 and US $68.32 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.5% during 2025-2030. This segment of the information and analytics industry involves applying data science and statistics to healthcare and biopharma data from genomic sequencing and clinical trials to manufacturing and commercial operations. Decision-makers are turning to analytics platforms and services that help sift through vast amounts of structured and unstructured information quickly. Several factors are driving this momentum, including surging data volumes, generative AI, cloud computing, and pressure for real-world evidence. The life sciences analytics market plays a critical role in helping pharmaceutical, biotechnology, and medical device companies turn complex data into actionable insights.

Report Overview: https://www.mordorintelligence.com/industry-reports/life-science-analytics-market?utm_source=openpr

Key Trends

1. Demand from Biomedical Data Surge

Life sciences organizations are grappling with enormous and diverse biomedical data-genomic, imaging, electronic health records, and RWE. The need to transform these into meaningful insights is a strong catalyst adding approximately 1.2% to CAGR through early 2027.

2. Regulatory Pressure & Evidence-Based Approval

In major markets like North America and Europe, regulators increasingly require data-driven proof for drug safety, efficacy, and post-market surveillance. This push adds about 1.0% to market CAGR and boosts investments in analytics tools over the next 2-4 years.

3. R&D Efficiency

With rising cost pressures on drug discovery and development, analytics are helping reshape experimental design and trial endpoints, contributing roughly 0.9% to CAGR over the next five years.

4. Multi‐modal & Cloud‐native Analytics

Precision medicine drives needs for analytics that unify genomic, clinical, and commercial data. a trend adding around 0.8% to CAGR in North America and APAC Meanwhile, infrastructure shifts toward real-time, cloud-based environments to accelerate insights and reduce IT overhead.

5. Outsourcing Surge

Life sciences are increasingly relying on analytics-focused vendors and AI-enabled CROs, contributing about 0.6% to CAGR, particularly in mature markets like North America, Europe, and the Asia‐Pacific region

Market Segmentation

By Product Type

Descriptive Analytics: Represented approximately 45 % of the market revenue in 2024. These tools focus on summarizing historical data-such as trial milestones, manufacturing quality issues, and sales trends-to support decision-making and monitoring.

Predictive Analytics: Used to forecast outcomes like patient enrollment success or manufacturing deviations, gaining ground on descriptive analytics as organizations look ahead rather than just review past events.

Prescriptive Analytics: Offers recommendations and optimizes actions such as adjusting trial parameters or route planning in supply chain. This segment is the fastest growing, with a projected CAGR of 13.5 % through 2030.

By Component

Software Platforms: These include analytics tools often embedded with data lakes, model development, visualization, and low-code interfaces. They led in growth potential, showing an 11.9 % CAGR from 2025 to 2030.

Services: Cover consulting, integration, training, and customization. They held a larger share in 2024 (~55.3%) due to complex implementation and adaptation needs.

By Deployment Mode

On-Premises: Dominant in 2024 (~64.8% of total deployment), favored for controlling sensitive data.

Cloud-Based: The fastest-growing option, with an estimated CAGR of 15.8 % through 2030. It offers scalability and elastic computing-especially useful for peak workloads like evidence processing.

By Application

Research & Development: Still the largest application area, with 41.7 % share in 2024. Analytics are applied in trial design, biomarker identification, and enrolment forecasting.

Sales, Marketing & Market Access: The fastest-growing application segment, with a CAGR of 12.8 % through 2030. RWE-driven customer segmentation, marketing campaign optimization, and pricing analysis are key use cases.

Other Applications (e.g., pharmacovigilance, safety, manufacturing QA/QC): While not separately quantified here, they're also part of the mixed use across the analytics landscape.

By End User

Pharmaceutical & Biotechnology Companies: Accounted for about 60.2 % of the total market share in 2024. Their heavy investment in pipelines, trials, and post-market surveillance keeps their usage dominant.

Medical Device Companies: Noted as the fastest-growing user group, with a CAGR of approximately 10.7 % through 2030. The surge comes from connected devices and the need for telemetry analysis and maintenance forecasting.

Other End Users: This includes institutions like CROs, academic research centers, and possibly government bodies-though specific figures aren't listed.

By Geography

North America: The leading region, holding 41.3 % of the market share in 2024. It benefits from mature R&D ecosystems, integrated data systems, and favourable regulations (e.g., FDA frameworks).

Asia‐Pacific: The region with the strongest projected growth, with an expected CAGR of 12.6 % from 2025 to 2030-driven by trial expansion, government incentives, and rising precision medicine efforts in China and India.

Europe, Middle East & Africa, South America: Important contributors-Europe with academic innovation and regulatory adaptation, and the MEA/LatAm regions growing gradually alongside their pharma infrastructure.

Explore Our Full Library of Healthcare Research Industry Reports: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

Leading multinational firms are shaping the life sciences analytics space by combining core technology with strategic partnerships and acquisitions. Major names include:

IBM - supports clinical trials and real-world data integration through its Watson and AI platforms.

Oracle - offers integrated data and analytics tools embedded in cloud infrastructure.

IQVIA - provides real-world evidence and advanced analytics through its clinical and commercial platforms.

SAS Institute - well known for statistical modelling, data integration, and regulatory-compliant analytics toolkits

These players are enhancing their offerings with AI, forging partnerships with CROs, and expanding globally to meet evolving customer needs. Mid-sized analytics specialists and AI-first start-ups are also actively challenging traditional models with focused offerings in trial design, multimodal integration, or data governance.

Conclusion

The life sciences analytics market is on track for significant growth as organizations strive to turn complex data into meaningful insights. With a projected expansion from US $39.83 billion in 2025 to US $68.32 billion by 2030, supported by an 11.5% annual growth rate, the market is moving toward cloud platforms, AI-driven tools, and global analytics services. Demand spans from R&D teams designing precision trials to commercial units optimizing field performance. While North America remains the dominant region, Asia‐Pacific is emerging fast, especially in India and China. Life sciences companies that harness analytics effectively stand to streamline operations, maintain compliance, and support better patient outcomes all while trimming time and cost in discovery.

Industry Related Reports

Life Science Tools Market : The Life Science Tools Market report segments the industry into By Type (Instruments, Consumables, Services), By Technology (PCR and qPCR, Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, and more), By Application (Proteomics Technology, Genomic Technology, and more), By End User (Research Laboratories, Diagnostic Laboratories, and more), and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/life-science-tools-market?utm_source=openpr

Life Science and Chemical Instrumentation Market: The Life Science & Chemical Instrumentation Market report segments the industry into By Technology (Polymerase Chain Reaction (PCR), DNA Sequencers & Amplifiers, and more), By End Users (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, and more), and Geography (North America, Europe, Asia-Pacific, and more).

Get More Insights: https://www.mordorintelligence.com/industry-reports/global-life-science-38-chemical-instrumentation-market-industry?utm_source=openpr

Life Science Reagents Market: The Life Science Reagents Market report segments the industry into By Product Type (Cell and Tissue Culture Reagents, Chromatography Reagents, Clinical Chemistry Reagents, Immunoassay Reagents, Molecular Diagnostic Reagents, Microbiology Reagents, and more), By End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and more), and By Geography (North America, Europe, and more).

Get More Insights: https://www.mordorintelligence.com/industry-reports/life-science-reagents-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com

This release was published on openPR.